Skip to main content
. 2014 Oct 1;27(5):329–340. doi: 10.1089/jamp.2013.1099

FIG. 4.

FIG. 4.

Relative in-vitro flow rate dependency of budesonide (a) and formoterol (b) FPD on 10th, 50th, and 90th percentile PIF rates for budesonide/formoterol Easyhaler 320/9 μg/inhalation (developmental and final formulation) and Symbicort forte Turbuhaler.